13.6C
Delhi
Tuesday, January 19, 2021

Russia’s Sputnik V Covid-19 vaccine claimed to be 95% effective

- Advertisement -

Russian vaccine arrives in India for human clinical trialMoscow, Nov 24 (IANS) Russia’s Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday.

The analysis was based on data from volunteers obtained 42 days after the first dose — which corresponds with 21 days after the second dose, Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Health Ministry and Russian Direct Investment Fund (RDIF), said.

And based on data obtained 28 days after administering the first dose – seven days after the second dose, the efficacy of the Sputnik V vaccine was found to be 91.4 per cent.

“The data demonstrating high efficacy of the Sputnik V vaccine gives us hope that we will soon obtain the most important tool in the fight against the pandemic of the novel coronavirus infection,” Russian Health Minister Mikhail Murashko said in a statement.

READ ALSO:  After 8-yr of negotiations, 15 Asia-Pacific countries sign RCEP

According to the protocol of Phase III clinical trials of the Sputnik V vaccine, its interim efficacy is calculated at three statistically significant representative control points — upon reaching 20, 39 and 78 cases of novel coronavirus infection among volunteers both in the placebo group and in the group that received the vaccine.

The second interim analysis of the Sputnik V vaccine efficacy was carried out on the basis of 39 confirmed cases identified in the placebo group (31 cases) and in the vaccine group (8 cases).

READ ALSO:  Advanced version of Swachh Bharat Mission in pipeline

The Russian vaccine uses two different vectors based on the human adenovirus, rather than using one and the same vector for two doses.

The next interim data analysis will be conducted upon reaching the third control point of 78 confirmed coronavirus cases among the study participants.

READ ALSO:  UK aviation sector calls for urgent support amid travel curbs

Final data analysis will be available by the end of Phase 3 clinical trials involving 40,000 volunteers.

Drug maker AstraZeneca on Monday said that its Covid-19 vaccine, developed with Oxford University, was up to 90 percent effective, making it one of the major drug companies after Pfizer and Moderna to have reported late-stage data for a potential Covid-19 vaccine.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India

Netaji’s birthday to be marked as ‘Parakram Diwas’ every year: Govt

New Delhi, Jan 19 (IANS) The Ministry of Culture on Tuesday said that the government has decided to celebrate the birthday of Netaji Subhas...

WHO panel highlights effective multilateralism in Covid response

Geneva, Jan 19 (IANS) A latest interim report by a WHO pandemic review panel has highlighted effective multilateralism in the preparation and response to...

Start of 2021 sees upward trend in Covid situation: WHO

Geneva, Jan 19 (IANS) Following two weeks of lower reporting towards the end of 2020, an overall upward trend of the Covid-19 pandemic has...

Petrol, diesel prices breach record high levels

New Delhi, Jan 19 (IANS) Petrol and diesel prices rose again by 25 paise per litre each on Tuesday after oil marketing companies decided...